Argenx
BiotechArgenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for autoimmune diseases and cancer.
2 companies tracked in our directory. Belgium hosts UCB and Janssen Pharmaceutica (Johnson & Johnson's biggest R&D site outside the US), regulated by FAMHP, the Federal Agency for Medicines and Health Products.
Try clearing your filters or refining your search keywords.
Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for autoimmune diseases and cancer.
UCB is a multinational biopharmaceutical company focusing on severe diseases in immunology and neurology, headquartered in Brussels, Belgium.